Methotrexate Recruiting Phase 2 Trials for chronic Chronic myelogenous leukemia / Hematopoietic Stem Cell Transplantation (HSCT) / Graft Versus Host Disease (GVHD) / Leukemia Acute Myeloid Leukemia (AML) / Acute Lymphoblastic Leukaemias (ALL) / Myelodysplastic Syndromes (MDS) / Chronic Myelomonocytic Leukemia (CMML) / Leukemias Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02663622Phase II Trial of CD24Fc for the Prevention of Acute GVHD Following Myeloablative Allogeneic HSCT
NCT02385110Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
NCT01920737A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
NCT03860844Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
NCT03913559Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia